<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00415987</url>
  </required_header>
  <id_info>
    <org_study_id>572</org_study_id>
    <nct_id>NCT00415987</nct_id>
  </id_info>
  <brief_title>Hematopoietic Stem Cell Transplantation in Myeloma</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera San Giovanni Battista</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera San Giovanni Battista</source>
  <brief_summary>
    <textblock>
      The treatment assignment is based on the presence or absence of an HLA-identical sibling&#xD;
      donor (Genetic Randomisation, NOT formal Randomisation). Patients with suitable HLA-identical&#xD;
      sibling donors are offered a tandem transplant approach consisting of standard autografting&#xD;
      nonmyeloablative radiotherapy and allografting. Patients without HLA-identical siblings are&#xD;
      treated with standard double autologous transplantation as per Institutional guidelines or&#xD;
      enrolled in other treatment programs approved by local IRBs.This is a multi-center study. The&#xD;
      Division of Hematology of University of Torino at the S.G.B. Hospital, Torino, Italy, is the&#xD;
      co-ordinating Center.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <completion_date>September 2006</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival Outcomes</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response Rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
  </secondary_outcome>
  <condition>Multiple Myeloma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hematopoietic Stem Cell Transplantation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Durie-Salmon stage IIA-IIIB multiple myeloma;&#xD;
&#xD;
          -  Age &gt; 18 and ≤ 65 years;&#xD;
&#xD;
          -  previously untreated myeloma;&#xD;
&#xD;
          -  presence of a sibling (potential donor);&#xD;
&#xD;
          -  bilirubins &lt; twice normal;ALAT and ASAT &lt; four times normal;&#xD;
&#xD;
          -  left ventricular ejection fraction &gt; 40%;&#xD;
&#xD;
          -  creatinine clearances &gt; 40 mL/min;&#xD;
&#xD;
          -  Pulmonary dysfunction with diffusing capacity for carbon monoxide (DLCO) &gt; 40% and/or&#xD;
             need for continuous oxygen supplementation;&#xD;
&#xD;
          -  Karnofsky performance status &gt; 60%;&#xD;
&#xD;
          -  patients must give written informed consent;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 65 years&#xD;
&#xD;
          -  previously treated myeloma;&#xD;
&#xD;
          -  absence of a sibling (genetic randomisation cannot be applied);&#xD;
&#xD;
          -  Karnofsky performance status score &lt; 60%&#xD;
&#xD;
          -  HIV-infection;&#xD;
&#xD;
          -  pregnancy;&#xD;
&#xD;
          -  Refusal to use contraceptive techniques during and for 12 months following treatment&#xD;
&#xD;
          -  patients unable to give written informed consent&#xD;
&#xD;
        PS. Informed consent is obtained from each patient according to the Institutional Review&#xD;
        Boards of the participating centers. The study is conducted according to the Declaration of&#xD;
        Helsinki.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benedetto Bruno, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Divisione Ematologia, Università di Torino, Azienda Ospedaliera San Giovanni Battista, Torino, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Boccadoro, MD</last_name>
    <role>Study Director</role>
    <affiliation>Divisione Ematologia, Università di Torino, Azienda Ospedaliera San Giovanni Battista, Torino, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ematologia Universitaria Azienda Ospedaliera San Giovanni Battista</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <study_first_submitted>December 26, 2006</study_first_submitted>
  <study_first_submitted_qc>December 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2006</study_first_posted>
  <last_update_submitted>June 19, 2008</last_update_submitted>
  <last_update_submitted_qc>June 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2008</last_update_posted>
  <keyword>Multiple Myeloma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

